Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshihiro Masaki

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Alcoholism, Clinical and Experimental Research|November 18, 2004
Association study of brain-derived neurotrophic factor gene polymorphism and alcoholismSachio Matsushita, Mitsuru Kimura, Tomohiro Miyakawa, et al.
Biochemical and Biophysical Research Communications|October 25, 2011
Histone deacetylase inhibitor trichostatin A enhances myogenesis by coordinating muscle regulatory factors and myogenic repressorsHiroki Hagiwara, Fumiaki Saito, Toshihiro Masaki, et al.
Journal of Neurochemistry|March 1, 2007
Defective peripheral nerve myelination and neuromuscular junction formation in fukutin-deficient chimeric miceFumiaki Saito, Toshihiro Masaki, Yuko Saito, et al.
Medical Electron Microscopy : Official Journal of the Clinical Electron Microscopy Society of Japan|October 18, 2005
Association of dystroglycan and laminin-2 coexpression with myelinogenesis in peripheral nervesToshihiro Masaki, Kiichiro Matsumura, Fumiaki Saito, et al.
Journal of the Peripheral Nervous System : JPNS|June 17, 2005
Harmful effects of anti-GalNAc-GD1a antibodies and TNF-alpha on rat dorsal root gangliaKeiko Kamakura, Ken-ichi Kaida, Susumu Kusunoki, et al.
Parkinsonism & Related Disorders|May 4, 2004
Therapeutic factors causing hallucination in Parkinson's disease patients, especially those given selegilineKeiko Kamakura, Hitoshi Mochizuki, Ken-ichi Kaida, et al.
Biochemical and Biophysical Research Communications|July 12, 2011
Secretion of N-terminal domain of α-dystroglycan in cerebrospinal fluidFumiaki Saito, Yuko Saito-Arai, Ayami Nakamura-Okuma, et al.
Experimental Neurology|March 1, 2002
Expression of dystroglycan and the laminin-alpha 2 chain in the rat peripheral nerve during developmentToshihiro Masaki, Kiichiro Matsumura, Akira Hirata, et al.
Human Molecular Genetics|April 12, 2014
Overexpression of LARGE suppresses muscle regeneration via down-regulation of insulin-like growth factor 1 and aggravates muscular dystrophy in miceFumiaki Saito, Motoi Kanagawa, Miki Ikeda, et al.
Journal of Neurology|September 25, 2003
Benign type of central pontine myelinolysis in alcoholism--clinical, neuroradiological and electrophysiological findingsHitoshi Mochizuki, Toshihiro Masaki, Tomohiro Miyakawa, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Alcoholism, Clinical and Experimental Research|November 18, 2004
Association study of brain-derived neurotrophic factor gene polymorphism and alcoholismSachio Matsushita, Mitsuru Kimura, Tomohiro Miyakawa, et al.
Biochemical and Biophysical Research Communications|October 25, 2011
Histone deacetylase inhibitor trichostatin A enhances myogenesis by coordinating muscle regulatory factors and myogenic repressorsHiroki Hagiwara, Fumiaki Saito, Toshihiro Masaki, et al.
Journal of Neurochemistry|March 1, 2007
Defective peripheral nerve myelination and neuromuscular junction formation in fukutin-deficient chimeric miceFumiaki Saito, Toshihiro Masaki, Yuko Saito, et al.
Medical Electron Microscopy : Official Journal of the Clinical Electron Microscopy Society of Japan|October 18, 2005
Association of dystroglycan and laminin-2 coexpression with myelinogenesis in peripheral nervesToshihiro Masaki, Kiichiro Matsumura, Fumiaki Saito, et al.
Journal of the Peripheral Nervous System : JPNS|June 17, 2005
Harmful effects of anti-GalNAc-GD1a antibodies and TNF-alpha on rat dorsal root gangliaKeiko Kamakura, Ken-ichi Kaida, Susumu Kusunoki, et al.
Parkinsonism & Related Disorders|May 4, 2004
Therapeutic factors causing hallucination in Parkinson's disease patients, especially those given selegilineKeiko Kamakura, Hitoshi Mochizuki, Ken-ichi Kaida, et al.
Biochemical and Biophysical Research Communications|July 12, 2011
Secretion of N-terminal domain of α-dystroglycan in cerebrospinal fluidFumiaki Saito, Yuko Saito-Arai, Ayami Nakamura-Okuma, et al.
Experimental Neurology|March 1, 2002
Expression of dystroglycan and the laminin-alpha 2 chain in the rat peripheral nerve during developmentToshihiro Masaki, Kiichiro Matsumura, Akira Hirata, et al.
Human Molecular Genetics|April 12, 2014
Overexpression of LARGE suppresses muscle regeneration via down-regulation of insulin-like growth factor 1 and aggravates muscular dystrophy in miceFumiaki Saito, Motoi Kanagawa, Miki Ikeda, et al.
Journal of Neurology|September 25, 2003
Benign type of central pontine myelinolysis in alcoholism--clinical, neuroradiological and electrophysiological findingsHitoshi Mochizuki, Toshihiro Masaki, Tomohiro Miyakawa, et al.
Pageof 3